Literature DB >> 26264134

Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: facial line satisfaction questionnaire.

Farrah Pompilus1, Somali Burgess2, Stacie Hudgens3, Benjamin Banderas1, Selena Daniels4.   

Abstract

BACKGROUND: Facial lines or wrinkles are among the most visible signs of aging, and minimally invasive cosmetic procedures are becoming increasingly popular. AIMS: The aim of this study was to develop and validate the Facial Line Satisfaction Questionnaire (FLSQ) for use in adults with upper facial lines (UFL).
METHODS: A literature review, concept elicitation interviews (n = 33), and cognitive debriefing interviews (n = 23) of adults with UFL were conducted to develop the FLSQ. The FLSQ comprises Baseline and Follow-up versions and was field-tested with 150 subjects in a US observational study designed to assess its psychometric performance. Analyses included acceptability (item and scale distribution [i.e. missingness, floor, and ceiling effects]), reliability, and validity (including concurrent validity).
RESULTS: In total, 69 concepts were elicited during patient interviews. Following cognitive debriefing interviews, the FLSQ-Baseline version included 11 items and the Follow-up version included 13 items. Response rates for the FLSQ were 100% and 73% at baseline and follow-up, respectively; no items had excessive missing data. Questionnaire scale scores were normally distributed. Most domain scores demonstrated good internal consistency reliability (Cronbach's α ≥ 0.70). Most items within their respective domains exhibited good convergent (item-scale correlations > 0.40) and discriminant (items had higher correlation with their hypothesized scales than other scales) validity. Concurrent validity correlation coefficients of the FLSQ domain scores with the associated concurrent measures were acceptable (range: r = 0.40-0.70). Six FLSQ items demonstrated reliability and validity as stand-alone items outside their domains.
CONCLUSIONS: The FLSQ is a valid questionnaire for assessing treatment expectations, satisfaction, impact, and preference in adults with UFL.
© 2015 The Authors. Journal of Cosmetic Dermatology Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  cosmetic; facial lines; patient satisfaction

Mesh:

Year:  2015        PMID: 26264134     DOI: 10.1111/jocd.12166

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  7 in total

1.  Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).

Authors:  Tjalf Ziemssen; Glenn Phillips; Ruchit Shah; Adam Mathias; Catherine Foley; Cheryl Coon; Rohini Sen; Andrew Lee; Sonalee Agarwal
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

2.  Patient-reported Outcomes in Chinese Subjects Treated with OnabotulinumtoxinA for Crow's Feet Lines.

Authors:  Yan Wu; Chengxin Li; Julia Garcia; Sarah Baradaran
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

3.  Safety and Efficacy of OnabotulinumtoxinA for Treatment of Crow's Feet Lines in Chinese Subjects.

Authors:  Yan Wu; Gang Wang; Chengxin Li; Cheri Mao; Xiaofang Lei; Elisabeth Lee
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-22

4.  The Psychological Impacts of Upper Facial Lines: A Qualitative, Patient-Centered Study.

Authors:  Steven Dayan; Steven G Yoelin; Koenraad De Boulle; Julie K Garcia
Journal:  Aesthet Surg J Open Forum       Date:  2019-05-06

5.  Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC).

Authors:  Anuj Shah; Xinyi Ng; Ruchit Shah; Caitlyn Solem; Ping Wang; Marko Obradovic
Journal:  Patient Relat Outcome Meas       Date:  2021-02-25

6.  Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines.

Authors:  John H Joseph; Corey Maas; Melanie D Palm; Edward Lain; Dee Anna Glaser; Suzanne Bruce; Steven Yoelin; Sue Ellen Cox; Steven Fagien; Sara Sangha; John Maltman; Xiaofang Lei; Mitchell F Brin
Journal:  Aesthet Surg J       Date:  2022-10-13       Impact factor: 4.485

7.  Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA Patient-Reported Outcome Guidance.

Authors:  Vaishali Patel; Elisabeth Lee; Michael B Silberberg
Journal:  Aesthet Surg J       Date:  2020-11-19       Impact factor: 4.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.